AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15174779
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (10 mg of elemental zinc daily)
Trial: 1618246
Drug: 4.4 ml
RxNorm normalized name: APONVIE 32 MG in 4.4 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.4 ml of 2% lignocaine with 1:80,000 adrenaline
Trial: 1618246
Drug: 3% prilocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% prilocaine with 0.03 IU.ml‐1 felypressin
Trial: 6367098
Drug: Atenolol 100
RxNorm normalized name: atenolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 100 mg plus chlorthalidone 25 mg (Tenoretic)
Trial: 6367098
Drug: Sotalol 320
RxNorm normalized name: sotalol 320 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotalol 320 mg plus hydrochlorothiazide 50 mg (Sotazide)
Trial: 28779419
Drug: Budesonide 2
RxNorm normalized name: budesonide 2 MG/ACTUAT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 2 mg/25 ml foam
Trial: 24731008
Drug: Low-dose fructose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose fructose infusion
Trial: 19889010
Drug: Fractional laser
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractional laser treatment (1,540-nm erbium glass laser)
Trial: 18418976
Drug: Yishen Tiaojing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yishen Tiaojing Recipe (YSTJR) plus TP 20 mg three times a day
Trial: 18418976
Drug: TP 20
RxNorm normalized name: 5-HTP 200 MG Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TP 20 mg three times a day (Control)
Trial: 10380745
Drug: Bupivacaine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (2.5 mg/ml) + epinephrine (5 microg/ml)
Trial: 10380745
Drug: Epinephrine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epinephrine (5 microg/ml) + saline (9 mg/ml)
Trial: 10380745
Drug: Saline (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (9 mg/ml) only
Trial: 9083303
Drug: Dilute vasopressin
RxNorm normalized name: Vasopressin
DrugBank: Vasopressin (DB00067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dilute vasopressin solution (0.05 U/mL)
Trial: 1998274
Drug: Lovastatin 20
RxNorm normalized name: lovastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin 20 or 40 mg once or twice daily
Trial: 31964335
Drug: Daily iron
RxNorm normalized name: Walgreens Multivitamin One Daily Iron-Free Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily iron supplementation of ferrous sulfate between 80 mg and 160 mg.
Trial: 30337921
Drug: HFA-134a-beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HFA-134a-beclomethasone dipropionate (HFA-BDP) metered-dose inhaler (MDI) ETN (n = 11)
Trial: 30337921
Drug: HFA-134a-beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HFA-134a-beclomethasone dipropionate (HFA-BDP) metered-dose inhaler (MDI) ETN
Trial: 27494176
Drug: GTE confection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GTE confection (1 g of green tea extract)
Trial: 24864465
Drug: Intravenous meldonium
RxNorm normalized name: meldonium
DrugBank: Meldonium (DB13723)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous meldonium (idrinol) 1000 mg/day for 10-14 days
Trial: 24864465
Drug: Basic therapy
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic therapy of coronary heart disease (Control Group)
Trial: 22439290
Drug: Problem-solving Treatment-OcOccupational
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Problem-solving Treatment-OcOccupational Therapy (PST-OT)
Trial: 19006186
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (on‐medication dyskinesia)
Trial: 12066244
Drug: 240 g
RxNorm normalized name: aspirin 15.6 GM (240 grains) Oral Bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 240 g of oral barium tracer
Trial: 12066244
Drug: 60 g
RxNorm normalized name: aspirin 60 Grains
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 g of oral barium tracer
Trial: 12066244
Drug: 150 g
RxNorm normalized name: TOCOPHEROL 2 g in 150 g TOPICAL OIL [TUREMRIC]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 g of oral barium tracer
Trial: 10434165
Drug: Granisetron 40
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron 40 mg kg‐1
Trial: 10434165
Drug: Dexamethasone 150
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone 150 mg kg‐1
Trial: 10434165
Drug: Granisetron 40
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron 40 mg kg‐1 plus Dexamethasone 150 mg kg‐1
Trial: 1721881
Drug: 3% polidocanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% polidocanol injection
Trial: 27537530
Drug: Outpatient management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outpatient management with oral rivaroxaban 15 mg twice daily for 21 days followed by 20 mg once daily for 90 days
Trial: 24240351
Drug: 5.0 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.0 mg/kg body weight of caffeine dissolved in 200 mL of water
Trial: 24240351
Drug: 200 mL
RxNorm normalized name: Bag Top-Fill, 1200 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mL of water (placebo)
Trial: 17234502
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group (n = 36) received weekly packets of fruits and vegetables, asked to consume >or=200 g of vegetables and two pieces of fruit daily for 1 month.
Trial: 15024533
Drug: Psychotropic medicines
RxNorm normalized name: Percy Medicine
DrugBank: Bismuth subsalicylate (DB01294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Psychotropic medicines use in the two least-educated groups
Trial: 15024533
Drug: Psychotropic medicines
RxNorm normalized name: Percy Medicine
DrugBank: Bismuth subsalicylate (DB01294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Psychotropic medicines use in the two highest educated groups
Trial: 15024533
Drug: Overall patterns
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall patterns of psychotropic medicine use
Trial: 11779909
Drug: Standard modalities
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard modalities of treatment (physiotherapy, occupational and speech therapy, skilled medical and nursing care)
Trial: 7652635
Drug: Ketanserin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin (10 mg IV)
Trial: 7652635
Drug: Hydralazine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydralazine (5 mg IV)
Trial: 2650942
Drug: Metoprolol 100
RxNorm normalized name: metoprolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 100 mg per os
Trial: 3072223
Drug: Nifedipine 10
RxNorm normalized name: nifedipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 10 mg 3 times daily
Trial: 389513
Drug: Nifedipine 10
RxNorm normalized name: nifedipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 10 mg 3 times daily + beta-blocker
Trial: 28182471
Drug: Cognitive remediation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive remediation program using computer software (CogPack; Japanese version), administered twice a week for 12 weeks, including a weekly group session.
Trial: 24276103
Drug: Intravenous piracetam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous piracetam
Trial: 24276103
Drug: Intravenous dimenhydrinate
RxNorm normalized name: Dimenhydrinate
DrugBank: Dimenhydrinate (DB00985)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous dimenhydrinate
Trial: 21159432
Drug: Pain assessment
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pain assessment using the pain subscale of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C‐30
Trial: 19681256
Drug: 5.9% hydrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.9% hydrogen peroxide paint‐on gel (Colgate Simply White)
Trial: 15478912
Drug: Daclizumab/MMF/Steroids (Tacrolimus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daclizumab/MMF/Steroids (Tacrolimus started when creatinine dropped below 350 micromol/l)
Trial: 15478912
Drug: Tacrolimus/MMF/Steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacrolimus/MMF/Steroids
Trial: 11675838
Drug: Heparin 1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin 1,000 units/kg
Trial: 11675838
Drug: NaCl 0.9%
RxNorm normalized name: DEXTROSE 5%/NACL 0.9% INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NaCl 0.9% 0.2 mL/kg (Control)
Trial: 9389779
Drug: 1 gram
RxNorm normalized name: guar gum 1 gram ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 gram gel containing 1 mg oestradiol for 3 months plus 20 mg oral MPA during the last 14 days
Trial: 9389779
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g gel containing 2 mg oestradiol for 21 days plus 10 mg oral MPA during the last 14 days
Trial: 9389779
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg oestradiol valerate tablets for 3 weeks plus 10 mg oral MPA during the last 10 days
Trial: 7701040
Drug: Buprenorphine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (8 mg sublingual, max 16 mg), average dose 11.2 mg
Trial: 7701040
Drug: Methadone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone (50 mg oral, max 90 mg), average dose 66.6 mg
Trial: 3115632
Drug: Melatonin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (500 mg at -60 min and at -30 min)
Trial: 3115632
Drug: Melatonin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (500 mg) prior to GRF 1-44 (1 micrograms/kg i.v. at 0 min)
Trial: 28224818
Drug: Low-dose docosahexaenoic
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose docosahexaenoic acid (DHA) (260 mg or 520 mg/day)
Trial: 27593174
Drug: Thrice-weekly insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thrice-weekly insulin degludec (IDeg) injected at twice the once-daily dose before lunch on Monday, Wednesday, and Friday
Trial: 24850107
Drug: ITM 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ITM 0.2 mg
Trial: 24850107
Drug: ITM 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ITM 0.5 mg
Trial: 24850107
Drug: ITM 1
RxNorm normalized name: Imatinib
DrugBank: Imatinib (DB00619)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: ITM 1 mg
Trial: 21226953
Drug: Cilostazol and
RxNorm normalized name: Cilostazol
DrugBank: Cilostazol (DB01166)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cilostazol and Probucol combination therapy
Trial: 24705623
Drug: Cilostazol monotherapy
RxNorm normalized name: Cilostazol
DrugBank: Cilostazol (DB01166)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cilostazol monotherapy
Trial: 18316488
Drug: Transcatheter PFO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcatheter PFO closure with the STARFlex implant
Trial: 1483490
Drug: Intravenous human
RxNorm normalized name: botulism immune globulin IV human Injection [BabyBIG]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous human calcitonin (hCT)
Trial: 3893112
Drug: Methylprednisolone 2
RxNorm normalized name: methylprednisolone 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone 2 mg/kg per day intravenously (n = 39)
Trial: 3893112
Drug: Cyclosporine (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine (12 to 15 mg/kg per day orally or 3 to 5 mg/kg per day intravenously) (n = 38)
Trial: 22747752
Drug: Synbiotic formulation
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Synbiotic formulation (Synbiotic 2000®) containing 4 strains of probiotic bacteria (10^10 each) plus 4 nondigestible, fermentable dietary fibers (2.5 g each) daily for 4 weeks
Trial: 22747752
Drug: Fiber-only placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fiber-only placebo formulation
Trial: 22747752
Drug: Synbiotic formulation
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Synbiotic formulation (Synbiotic 2000®)
Trial: 8562299
Drug: Felbamate 1200
RxNorm normalized name: Felbamate
DrugBank: Felbamate (DB00949)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Felbamate 1200 mg every 12 h with vigabatrin 1000 mg every 12 h
Trial: 8562299
Drug: Vigabatrin 1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vigabatrin 1000 mg every 12 h with felbamate 1200 mg every 12 h
Trial: 466335
Drug: Intravenous on-demand
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous on-demand fentanyl infusion
Trial: 466335
Drug: Epidural injections
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural injections of bupivacaine
Trial: 28468648
Drug: Counseling plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Counseling plus Expedited Partner Therapy (EPT) with cefixime 400 mg/azithromycin 1 g for up to five recent partners; n=89.
Trial: 22664861
Drug: Rapid enteral
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid enteral feeding advancement (30 mL/kg/d)
Trial: 22664861
Drug: Slow enteral
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow enteral feeding advancement (20 mL/kg/d)
Trial: 21654257
Drug: Moderate alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Moderate alcohol intake (≤14 g/day)
Trial: 21654257
Drug: Heavy alcohol
RxNorm normalized name: heavy mineral oil
DrugBank: Mineral oil (DB11057)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heavy alcohol intake (>14 g/day)
Trial: 16942571
Drug: Drugs only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drugs only (Control)
Trial: 2648792
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg acetylsalicylic acid (ASA) once daily
Trial: 30880405
Drug: Antidepressants (three
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressants (three types, unspecified)
Trial: 21530211
Drug: n-3 polyunsaturated
RxNorm normalized name: Omega-3 (n-3) polyunsaturated fatty acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 polyunsaturated fatty acids (PUFA) 2.4 g
Trial: 11130217
Drug: LTG 100
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LTG 100 mg with steady‐state BUP 150 mg twice/day
Trial: 11130217
Drug: LTG 100
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LTG 100 mg
Trial: 9316823
Drug: ISIS 2302
RxNorm normalized name: ISIS-APOCIII-LRX
DrugBank: Olezarsen (DB18728)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ISIS 2302 (0.06-2.00 mg/kg infused over 2 hr)
Trial: 8287864
Drug: Allopurinol in
RxNorm normalized name: allopurinol Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol in the cardioplegic solution
Trial: 8287864
Drug: Trimetazidine pre-treatment
RxNorm normalized name: trimetazidine
DrugBank: Trimetazidine (DB09069)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimetazidine pre-treatment and addition to the cardioplegic solution
Trial: 3817280
Drug: Tioconazole cream
RxNorm normalized name: Tioconazole
DrugBank: Tioconazole (DB01007)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tioconazole cream 1%
Trial: 31784988
Drug: Intrathecal baclofen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal baclofen (ITB) treatment
Trial: 28744742
Drug: non-treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: non-treatment
Trial: 25465324
Drug: BMS plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMS plus drug coated balloon (DCB)
Trial: 23127306
Drug: oral hygiene
RxNorm normalized name: HYDROGEN PEROXIDE 2.94 mL in 2.94 mL ORAL SPRAY [OROXID Forte Oral Hygiene]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral hygiene instruction and chlorhexidine mouthrinse
Trial: 23127306
Drug: oral hygiene
RxNorm normalized name: HYDROGEN PEROXIDE 2.94 mL in 2.94 mL ORAL SPRAY [OROXID Forte Oral Hygiene]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral hygiene instruction, chlorhexidine mouthrinse, and assisted brushing
Trial: 23127306
Drug: oral hygiene
RxNorm normalized name: HYDROGEN PEROXIDE 2.94 mL in 2.94 mL ORAL SPRAY [OROXID Forte Oral Hygiene]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral hygiene instruction alone
Trial: 21047828
Drug: NVP200 (nevirapine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NVP200 (nevirapine initiation by dose escalation)
Trial: 21047828
Drug: NVP400 (nevirapine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NVP400 (nevirapine initiation at 200 mg twice daily)
Trial: 18799723
Drug: CHVP+I (chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHVP+I (chemotherapy plus interferon)
Trial: 1750722
Drug: Terfenadine, 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine, 120 mg twice a day
Trial: 7127660
Drug: Oral adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral adjuvant razoxane (ICRF-159)
Trial: 28576557
Drug: Ethanol lock
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ethanol lock therapy (ELT)
Trial: 24183730
Drug: Pelvic floor
RxNorm normalized name: Tenscare Kegel Toner Pelvic Floor Trainer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pelvic floor muscle training/behavioral therapy
Trial: 17549054
Drug: Fresh frozen
RxNorm normalized name: Fresh frozen plasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresh frozen plasma (FFP) infusions
Trial: 17549054
Drug: No fresh
RxNorm normalized name: Aveeno Fresh Greens Blend Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No fresh frozen plasma (FFP) infusions
Trial: 10879067
Drug: Various treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various treatments for atherosclerosis; specific interventions not detailed in the abstract.
Trial: 8445289
Drug: Thromboxane synthase
RxNorm normalized name: Thromboxane synthase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thromboxane synthase inhibitor (FCE 22178, 400 mg two or three times per day)
Trial: 16356945
Drug: Referral to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Referral to a genitourinary medicine clinic
Trial: 10799728
Drug: Post-mastectomy irradiation
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-mastectomy irradiation plus systemic treatment
Trial: 11384568
Drug: Brimonidine 0.2%
RxNorm normalized name: BRIMONIDINE 0.2%/TIMOLOL 0.5% OPH SOLN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brimonidine 0.2% three times daily
Trial: 19697094
Drug: Interpersonal Psychotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interpersonal Psychotherapy group (IPT-G)
Trial: 17242805
Drug: Nizatidine 600
RxNorm normalized name: Nizatidine
DrugBank: Nizatidine (DB00585)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nizatidine 600 mg
Trial: 12809451
Drug: Morning insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning insulin glargine + 3 mg glimepiride
Trial: 12809451
Drug: Bedtime insulin
RxNorm normalized name: Buckley's Bedtime Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bedtime insulin glargine + 3 mg glimepiride
Trial: 12809451
Drug: Bedtime NPH
RxNorm normalized name: Buckley's Bedtime Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bedtime NPH insulin + 3 mg glimepiride
Trial: 16513202
Drug: Morning insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning insulin glargine
Trial: 12809451
Drug: Bedtime insulin
RxNorm normalized name: Buckley's Bedtime Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bedtime insulin glargine
Trial: 10810461
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment protocols for osteosarcoma (same as used for adolescents)
Trial: 10810461
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment protocols for osteosarcoma
Trial: 8861695
Drug: Loading dose
RxNorm normalized name: NUZYRA 7-Day Oral Pack including loading dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loading dose of 10 mg/kg of phenytoin (group A, n = 10)
Trial: 8861695
Drug: Loading dose
RxNorm normalized name: NUZYRA 7-Day Oral Pack including loading dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loading dose of 15 mg/kg of phenytoin (group B, n = 10)
Trial: 8861695
Drug: PHT maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PHT maintenance treatment (250 mg, i.v., every 8 hours)
Trial: 27387676
Drug: Preoperative chemotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative chemotherapy followed by tumor resection
Trial: 22124712
Drug: Melatonin administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin administration prior to EEG recording